Global Stem Cell Banking Market, By Source (Placental Stem Cells (PSCs), Human Embryo-Derived Stem Cells (hESCs), Bone Marrow-Derived Stem Cells (BMSCs), Dental Pulp-Derived Stem Cells (DPSCS), Adipose Tissue-Derived Stem Cells (ADSCs), Other Stem Cell Sources), Product (Adult Stem Cells, Human Embryonic Cells, IPS Cells), Bank Type (Private, Public), Service Type (Sample Collection and Transportation, Sample Processing, Sample Analysis, Sample Preservation, Storage), Utilization (Used, Unused), Application (Personalized Storage, Clinical, Research) – Industry Trends and Forecast to 2029.
Global Stem Cell Banking Market Analysis and Size
The market is expected to expand over the forecasted time period as there has been surge in number of people fatal chronic conditions over the past few years. According to the Centers for Disease Control and Prevention (CDC), roughly 3,613,647 babies will be reported in 2020. The surge in chronic diseases will increase the spending on managing chronic diseases, which will aid the market. Consequently, the market is being propelled forward with various growth determinants and is projected to show substantial growth over the forecasted period.
- Global Stem Cell Banking Market was valued at USD 4,990.56 million in 2021 and is expected to reach USD 16,474.30 million by 2029, registering a CAGR of 16.1% during the forecast period of 2022-2029. The “adult stem cells” accounts for the largest product segment in the stem cell banking market within the forecasted period owing to its advantages such as the high acceptance in the human body, ease of harvesting and effectiveness in tissue generation. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Global Stem Cell Banking Market Definition
Stem cells are cells that can self-renew and differentiate into a variety of cell lineages. These can be found in all stages of life in humans, from infancy to death. The stem cell banking technique involves storing stem cells from a variety of sources and is widely used in research and clinical settings.
Report Scope and Market Segmentation
2022 to 2029
2020 (Customizable to 2019 - 2014)
Revenue in USD Million, Volumes in Units, Pricing in USD
By Source (Placental Stem Cells (PSCs), Human Embryo-Derived Stem Cells (hESCs), Bone Marrow-Derived Stem Cells (BMSCs), Dental Pulp-Derived Stem Cells (DPSCS), Adipose Tissue-Derived Stem Cells (ADSCs), Other Stem Cell Sources), Product (Adult Stem Cells, Human Embryonic Cells, IPS Cells), Bank Type (Private, Public), Service Type (Sample Collection and Transportation, Sample Processing, Sample Analysis, Sample Preservation, Storage), Utilization (Used, Unused), Application (Personalized Storage, Clinical, Research)
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
Market Players Covered
CBR Systems, Inc., (U.S.), Cordlife (Singapore), Cryo-Cell International, Inc., (U.S.), ViaCord (U.S.), Cryo-Save (Netherlands), LifeCell International Pvt. Ltd. (India), StemCyte India Therapeutics Pvt. Ltd (U.S.), Global Cord Blood Corporation (China), Smart Cells International Limited (UK), Vita34 1997 (Germany), Caladrius Biosciences, Inc. (U.S.), Celgene Corporation (U.S.), BrainStorm Cell Limited (U.S.), Regrow Biosciences Pvt. Ltd. (India) and CryoHoldco (Mexico)
Stem Cell Banking Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Surging Requirement for Stem Cell Banking
The increase in the global burden of major diseases and rise in the use of stem cell banking for curing badly damaged tissues are the most significant factors driving this market's growth. The surge in hematopoietic stem cell transplantation procedures and the increase in the number of skin transplants and brain cell transplantations are also expected to accelerate the market's overall growth.
- Surging Awareness
The various initiatives for instilling awareness amongst consumers by government as well as non-government organizations about the therapeutic potentials of stem cells will bolster the overall growth of the market.
Furthermore, the rise in population and expansion of biotechnology sector are also expected to fuel market growth. Moreover, the rise in gross domestic product (GDP) of respective underdeveloped and developing economies also cushions the market’s growth within the forecasted period. The increasing approval of clinical trials in stem cell research is also projected to bolster the market's growth.
- Growing Investments and Advancements
Moreover, the development of novel technologies for stem cell preservation, processing and storage are estimated to generate lucrative opportunities for the market. The increasing investments in stem cell-based research will further offer numerous growth opportunities for the market.
Restraints/Challenges Global Stem Cell Banking Market
- High Costs
On the other hand, the high operational costs of stem cell transplantation is expected to obstruct market growth.
Also, the stringent regulatory frameworks and socio-ethical concerns related to embryonic stem cells are projected to challenge the stem cell banking market in the forecast period of 2022-2029.
This stem cell banking market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the stem cell banking market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Stem Cell Banking Market
The outbreak of COVID-19 is expected to have a negative impact on the stem cell banking industry's growth. COVID-19 further resulted in a severe public health concern. The government's imposition of the lockdown and social distancing restrictions to curb the COVID-19 pandemic outbreak led to halt of various stem cell harvest processes, supply chain disruptions, stifling business growth, technology event cancellations suspensions of new developments and has affected the overall production and sales.
On the brighter side, the clinical trials for the use of stem cells in the treatment of COVID-19, could help the industry flourish after the pandemic. With gradual increment in clinical trials for usage of stem cells treatment, the market will witness a lucrative growth.
- In February 2021, BioTherapeutic Labs Corp and American CryoStem, a biotechnology business, have engaged into a collaboration agreement for stem cell research and development. BTL will sell CRYO's goods and services, and the two companies will collaborate on R&D efforts to create and improve protocols that use CRYO's ATCell® autologous mesenchymal stem cells and BTL's human umbilical cord-based product lines. The companies intend to validate and standardize the umbilical cord acellular suspension product for use with their ATCellTM manufacturing, product development, and end-to-end CryoStem Platform Technology.
Global Stem Cell Banking Market Scope
The stem cell banking market is segmented on the basis of source, product, bank type, service type, utilization and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Placental Stem Cells (PSCs)
- Human Embryo-Derived Stem Cells (hESCs)
- Bone Marrow-Derived Stem Cells (BMSCs)
- Dental Pulp-Derived Stem Cells (DPSCS)
- Adipose Tissue-Derived Stem Cells (ADSCs)
- Other Stem Cell Sources
On the basis of source, the stem cell banking market is segmented into placental stem cells (PSCs), human embryo-derived stem cells (hESCs), bone marrow-derived stem cells (BMSCs), dental pulp-derived stem cells (DPSCS), adipose tissue-derived stem cells (ADSCs) and other stem cell sources.
- Adult Stem Cells
- Human Embryonic Cells
- IPS Cells
On the basis of product, the stem cell banking market is segmented into adult stem cells, human embryonic cells and IPS cells. The adult stem cells is projected to show largest market share over the forecasted period because of its advantages such as the high acceptance in the human body, ease of harvesting and effectiveness in tissue generation.
On the basis of bank type, the stem cell banking market is segmented into private and public.
- Sample Collection and Transportation
- Sample Processing, Sample Analysis
- Sample Preservation, Storage
On the basis of service type, the stem cell banking market is segmented into sample collection and transportation, sample processing, sample analysis, sample preservation and storage.
On the basis of utilization, the stem cell banking market is segmented into used and unused.
- Personalized Storage
On the basis of application, the stem cell banking market is bifurcated into personalized storage, clinical and research.
Stem Cell Banking Market Regional Analysis/Insights
The stem cell banking market is analyzed and market size insights and trends are provided by country, source, product, bank type, service type, utilization and application as referenced above.
The countries covered in the stem cell banking market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the stem cell banking market because of the prevalence of chronic diseases and expanding network of stem cell banking services within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in patient population along with the developing healthcare infrastructure within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The stem cell banking market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for stem cell banking market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the stem cell banking market. The data is available for historic period 2010-2020.
Competitive Landscape and Stem Cell Banking Market Share Analysis
The stem cell banking market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to stem cell banking market.
Some of the major players operating in the stem cell banking market are
- CBR Systems, Inc., (U.S.)
- Cordlife (Singapore)
- Cryo-Cell International, Inc., (U.S.)
- ViaCord (U.S.)
- Cryo-Save (Netherlands)
- LifeCell International Pvt. Ltd. (India)
- StemCyte India Therapeutics Pvt. Ltd (U.S.)
- Global Cord Blood Corporation (China)
- Smart Cells International Limited (UK)
- Vita34 1997 (Germany)
- Caladrius Biosciences, Inc. (U.S.)
- Celgene Corporation (U.S.)
- BrainStorm Cell Limited (U.S.)
- Regrow Biosciences Pvt. Ltd. (India)
- CryoHoldco (Mexico)
- Cryo-Save (Netherlands)
Research Methodology : Global Stem Cell Banking Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-stem-cell-banking-market